Core Viewpoint - Fosun Pharma has announced the sale of its subsidiary, Henan Fosun Smart Energy Technology Co., Ltd., to Henan Xisheng Industrial Development Co., Ltd. for a total consideration of RMB 73 million, as part of a strategic move to streamline operations and focus on its core pharmaceutical business [1][3]. Group 1: Company Overview - The target company, Henan Fosun Smart Energy Technology Co., Ltd., was established on February 22, 2023, with a registered capital of RMB 50 million, fully paid [2]. - The company primarily engages in the installation and operation of photovoltaic power generation systems, which are used to support the internal power needs of the pharmaceutical group and for external sales [2]. Group 2: Business Operations - As of the announcement date, the target company operates three photovoltaic power generation systems with installed capacities of approximately 6.089 MW, 6.387 MW, and 14.886 MW [2]. - The systems with capacities of 6.089 MW and 6.387 MW were installed in March and May 2023, respectively, and commenced operation in June and August 2023 [2]. - The 14.886 MW system began installation in September 2024, passed inspection in February 2025, and is expected to start operations in June 2025 [2]. Group 3: Strategic Rationale - The sale of the non-core subsidiary aligns with the company's long-term strategy to streamline operations and refocus on its core pharmaceutical business [3]. - The proceeds from the sale will provide immediate cash inflow, intended for general working capital, including operational expenses and support for the ongoing development of the core pharmaceutical business [3].
福森药业拟7300万元出售光伏发电系统公司100%股权 聚焦制药主业